The insurance industry's greatest success isn't denying claims. It's getting you to not appeal them.

Here's a fact that changes the entire conversation: 80% of denied claims are overturned on appeal.

But here's the kicker: Less than 1% of denials are ever appealed.

That gap is not an accident. It's the entire business model.

The Numbers Nobody's Talking About

Let's start with the macro:

  • 475 million claims submitted annually in the U.S.
  • 19% of those are denied. That's ~90 million denials per year.
  • Less than 1% are appealed. That's ~900,000 appeals.
  • 80%+ of those appeals are won. That's ~720,000 successful appeals.
  • $26 billion in preventable denials never get challenged.

Think about that for a second. $26 billion leaves the healthcare system every year because patients and providers don't appeal claims that would almost certainly be overturned.

Insurance companies are betting on your inaction. And they're winning that bet spectacularly.

The Economics of a Single Denial

Let's make this concrete with a surgical case:

The Knee Replacement Math

Base claim value: $25,000

Payer denial rate (UHC surgical procedures): 12%

Probability denial would be overturned on appeal: 80%

Cost to appeal (RCM staff time, documentation): $500

Expected recovery if you appeal: $25,000 × 0.80 = $20,000

Expected value of appealing: $20,000 - $500 = $19,500

Most likely outcome if you don't appeal: You lose $25,000 and the claim vanishes

This is the simplest cost-benefit analysis in healthcare. You spend $500 to have an 80% chance of recovering $25,000. The expected value is $19,500 per appeal.

Yet health systems don't appeal. Why?

The Three Reasons Denials Don't Get Appealed

Reason 1: The Revenue Never Looks Lost

When a claim gets denied, it doesn't show up in accounting as a lost $25,000. It shows up as an "account receivable" that never gets paid. From the hospital's perspective, it was never revenue. So there's no perceived "loss" to fight.

Compare that to a patient experience: If you were charged $25,000 for a knee replacement and the insurance company refused to pay, you'd fight them. Because you see the $25,000 leaving your account.

Health systems don't see the denial as a loss. They see it as a noncollection. Different mindset. Less urgency.

Reason 2: The Appeal System Is Designed to Be Painful

Appealing a denial requires:

  • Pulling the original claim and supporting documentation
  • Understanding the specific denial reason
  • Drafting a response that addresses the payer's concern
  • Submitting through the correct channel (each payer has different portals/processes)
  • Following up when the payer ignores the appeal
  • Escalating to external review if the payer denies the first appeal (which happens 30-40% of the time)

This is labor-intensive. Your RCM team is already at 85% capacity. Adding another step to a low-priority process (a patient already received care, so it feels like sunk cost) means the appeal never happens.

Insurance companies designed this system knowing that operational friction converts potential appeals into abandoned claims. It's brilliant.

Reason 3: You Don't Know Which Denials Will Win

Here's the critical one: Not all denials are equal.

Some denials are defensible. The patient truly didn't meet clinical criteria. The authorization was genuinely missing. These should be accepted and the case closed.

But many denials are not defensible. They're using policy language to deny clinically appropriate care. They're applying criteria that contradict the payer's own standards. They're exploiting documentation technicalities.

Your RCM team doesn't know which is which. So they treat all denials the same: file them away and move on. If you appeal the defensible ones, you waste time and lose credibility with the payer.

You need intelligence about which denials are winnable. Without it, you appeal blindly or not at all.

The Actuarial Reality

Insurance companies run the math daily:

Scenario Payer Perspective Probability Payer Outcome Provider appeals (80% win rate) Lose 80% of appealed claims 0.01 (1% appeal rate) Lose 0.8% of denied value Provider doesn't appeal Keep 100% of denied value 0.99 (99% non-appeal rate) Keep 99% of denied value Net result: Payer keeps ~98% of denied value

This is the hidden spreadsheet that runs every insurance company's denial operations.

They know they can deny clinically appropriate care at a 5-15% rate and keep most of the money. Because you won't appeal. Because appealing is hard. Because you don't know if you'll win.

What Changes The Equation

Three things move the needle:

1. Visibility Into Win Probability

If you know that denial code CO-50 from UHC has an 87% appeal win rate, you appeal it. If you know it has a 23% win rate, you don't. The knowledge itself changes your behavior.

2. Automation of the Appeal Process

If appealing takes 15 minutes per claim instead of 2 hours, you appeal more. The same economics apply, but the friction disappears.

3. Bundling Appeals With Denial Prevention

Most value comes from preventing denials before they happen, not appealing after. If you know that UHC denies knee replacements without specific imaging protocols, you add those protocols to your pre-submission checklist. You prevent the denial. You never have to appeal.

But while denials will always happen, appealing them is still the highest ROI activity in revenue cycle operations.

"An 80% win rate on $25,000 claims at a $500 cost per appeal is a 40:1 return on investment. There is literally no other RCM activity with returns this high. Yet denials don't get appealed."

The Math Says You Should Appeal Everything

Let's be precise: Not every denial should be appealed. Some are correct. Some cost more to appeal than they recover.

But here's what the math actually says you should do:

  • Denials over $5,000 should always appeal. The 80% win rate makes the math work at any cost.
  • Denials from high-frequency payers (UHC, Anthem, Aetna) should appeal as a class. If your data shows UHC denies CO-50 codes at 12% with 85% appeal win rate, appeal every single one.
  • Denial patterns (clustered denials from one payer on one code) should trigger an RCM protocol. Investigate, then appeal systematically.
  • Denials from high-margin payers should appeal. If Cigna has $10M in claims and 15% denial rate, that's $1.5M at stake. The economics are overwhelming.

Most health systems appeal less than 0.5% of denials. The math suggests you should appeal 5-10%.

That's not aggressive. That's rational.

The Real Opportunity

Let's say you're a 300-bed health system with $450M in annual claims. At 19% denial rate, that's $85.5M in denied value.

Current state: You appeal 0.5%. You get back $34.2M (at 80% win rate). You leave $51.3M on the table.

Optimized state: You appeal 5% intelligently (high-value claims + high-frequency payer patterns). You get back $340M. You're not leaving $51.3M on the table anymore.

For a regional health system, that's $25-50M in recovered revenue. Not revenue from new patients or new services. Revenue that you earned but didn't collect because you didn't appeal claims you should have won.

That's not optimization. That's leaving money on the table.

"Insurance companies are counting on the fact that you won't appeal. The math says you should prove them wrong."